• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金属有机框架:对抗 COVID 的非传统纳米武器

Metal-Organic Frameworks: Unconventional Nanoweapons against COVID.

机构信息

Advanced Porous Materials Unit, IMDEA Energy, Ramón de la Sagra 3, 28935 Móstoles-Madrid, Spain.

Wallenberg Initiative Materials Science for Sustainability, Department of Materials and Environmental Chemistry, Stockholm University, Stockholm 106 91, Sweden.

出版信息

ACS Appl Mater Interfaces. 2024 Jun 26;16(25):32118-32127. doi: 10.1021/acsami.4c06174. Epub 2024 Jun 11.

DOI:10.1021/acsami.4c06174
PMID:38862123
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11212624/
Abstract

The SARS-CoV-2 (COVID-19) pandemic outbreak led to enormous social and economic repercussions worldwide, felt even to this date, making the design of new therapies to combat fast-spreading viruses an imperative task. In the face of this, diverse cutting-edge nanotechnologies have risen as promising tools to treat infectious diseases such as COVID-19, as well as challenging illnesses such as cancer and diabetes. Aside from these applications, nanoscale metal-organic frameworks (nanoMOFs) have attracted much attention as novel efficient drug delivery systems for diverse pathologies. However, their potential as anti-COVID-19 therapeutic agents has not been investigated. Herein, we propose a pioneering anti-COVID MOF approach by studying their potential as safe and intrinsically antiviral agents through screening various nanoMOF. The iron(III)-trimesate MIL-100 showed a noteworthy antiviral effect against SARS-CoV-2 at the micromolar range, ensuring a high biocompatibility profile (90% of viability) in a real infected human cellular scenario. This research effectively paves the way toward novel antiviral therapies based on nanoMOFs, not only against SARS-CoV-2 but also against other challenging infectious and/or pulmonary diseases.

摘要

SARS-CoV-2(COVID-19)大流行在全球范围内造成了巨大的社会和经济影响,甚至到今天仍能感受到,因此设计新的疗法来对抗快速传播的病毒是当务之急。面对这种情况,各种前沿的纳米技术已经成为治疗 COVID-19 等传染病以及癌症和糖尿病等挑战性疾病的有前途的工具。除了这些应用之外,纳米级金属有机骨架(nanoMOF)作为治疗各种疾病的新型高效药物输送系统也引起了广泛关注。然而,它们作为抗 COVID-19 治疗剂的潜力尚未得到研究。在这里,我们通过筛选各种 nanoMOF 来研究它们作为安全和固有抗病毒药物的潜力,提出了一种开创性的抗 COVID MOF 方法。三价铁-均苯三甲酸 MIL-100 在微摩尔范围内对 SARS-CoV-2 表现出显著的抗病毒作用,在真实感染的人类细胞环境中确保了高生物相容性(90%的存活率)。这项研究为基于 nanoMOF 的新型抗病毒疗法铺平了道路,不仅针对 SARS-CoV-2,还针对其他具有挑战性的传染病和/或肺部疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91c/11212624/ff326754cff9/am4c06174_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91c/11212624/15c74917240b/am4c06174_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91c/11212624/1ca12f9290b4/am4c06174_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91c/11212624/ff326754cff9/am4c06174_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91c/11212624/15c74917240b/am4c06174_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91c/11212624/1ca12f9290b4/am4c06174_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91c/11212624/ff326754cff9/am4c06174_0003.jpg

相似文献

1
Metal-Organic Frameworks: Unconventional Nanoweapons against COVID.金属有机框架:对抗 COVID 的非传统纳米武器
ACS Appl Mater Interfaces. 2024 Jun 26;16(25):32118-32127. doi: 10.1021/acsami.4c06174. Epub 2024 Jun 11.
2
The potential of metal-organic framework MIL-101(Al)-NH in the forefront of antiviral protection of cells via interaction with SARS-CoV-2 spike RBD protein and their antibacterial action mediated with hypericin and photodynamic treatment.金属有机框架MIL-101(Al)-NH通过与SARS-CoV-2刺突RBD蛋白相互作用在细胞抗病毒保护前沿的潜力及其由金丝桃素和光动力处理介导的抗菌作用。
J Colloid Interface Sci. 2025 Aug;691:137454. doi: 10.1016/j.jcis.2025.137454. Epub 2025 Mar 26.
3
Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants.SARS-CoV-2 及其新兴变异株的进入抑制剂的发现和评估。
J Virol. 2021 Nov 23;95(24):e0143721. doi: 10.1128/JVI.01437-21. Epub 2021 Sep 22.
4
Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.具有体外抗病毒活性和免疫调节作用的半胱胺有可能成为治疗 COVID-19 的重新定位药物候选物。
Cells. 2021 Dec 24;11(1):52. doi: 10.3390/cells11010052.
5
Nanotechnology-Driven Strategy Against SARS-CoV-2: Pluronic F127-Based Nanomicelles with or Without Atazanavir Reduce Viral Replication in Calu-3 Cells.纳米技术驱动的抗SARS-CoV-2策略:含或不含阿扎那韦的基于普朗尼克F127的纳米胶束可减少Calu-3细胞中的病毒复制
Viruses. 2025 Apr 1;17(4):518. doi: 10.3390/v17040518.
6
Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.宿主细胞丝氨酸蛋白酶抑制剂 MM3122 治疗和预防 COVID-19 中对 SARS-CoV-2 的疗效。
J Virol. 2024 May 14;98(5):e0190323. doi: 10.1128/jvi.01903-23. Epub 2024 Apr 9.
7
Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches.运用计算机模拟和体外实验方法鉴定和重新利用抗严重急性呼吸综合征冠状病毒2的抗病毒药物。
Biochem Biophys Res Commun. 2021 Jan 29;538:137-144. doi: 10.1016/j.bbrc.2020.10.094. Epub 2020 Nov 20.
8
Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms.姜黄素通过多种抗病毒机制抑制 Vero E6 细胞中的体外 SARS-CoV-2 感染。
Molecules. 2021 Nov 16;26(22):6900. doi: 10.3390/molecules26226900.
9
Noble Metal Organometallic Complexes Display Antiviral Activity against SARS-CoV-2.贵金属有机金属配合物对 SARS-CoV-2 显示抗病毒活性。
Viruses. 2021 May 25;13(6):980. doi: 10.3390/v13060980.
10
IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.在研 DHODH 抑制剂 IMU-838 治疗自身免疫性疾病进入 II 期,在体外显示出抗 SARS-CoV-2 和广谱抗病毒活性。
Viruses. 2020 Dec 5;12(12):1394. doi: 10.3390/v12121394.

引用本文的文献

1
Dynamic Flow-Assisted Nanoarchitectonics.动态流动辅助纳米结构技术
ACS Appl Mater Interfaces. 2025 Apr 30;17(17):24778-24806. doi: 10.1021/acsami.5c03820. Epub 2025 Apr 21.

本文引用的文献

1
Metal organic framework-based variable-size nanoparticles for tumor microenvironment-responsive drug delivery.基于金属有机框架的可变尺寸纳米颗粒用于肿瘤微环境响应性药物递送。
Drug Deliv Transl Res. 2024 Jul;14(7):1737-1755. doi: 10.1007/s13346-023-01500-x. Epub 2024 Feb 8.
2
Recent advances in metal-organic frameworks for stimuli-responsive drug delivery.金属有机骨架在刺激响应型药物递送上的最新进展。
Nanoscale. 2024 Feb 29;16(9):4434-4483. doi: 10.1039/d3nr05776c.
3
A review of SARS-CoV-2 drug repurposing: databases and machine learning models.
新型冠状病毒2型药物重新利用综述:数据库与机器学习模型
Front Pharmacol. 2023 Aug 4;14:1182465. doi: 10.3389/fphar.2023.1182465. eCollection 2023.
4
Nanoparticle-Based Strategies to Combat COVID-19.基于纳米颗粒的抗击新冠病毒策略
ACS Appl Nano Mater. 2020 Aug 25;3(9):8557-8580. doi: 10.1021/acsanm.0c01978. eCollection 2020 Sep 25.
5
The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art.鞣花酸治疗肿瘤的多效机制:最新研究进展。
Biomed Pharmacother. 2023 Sep;165:115132. doi: 10.1016/j.biopha.2023.115132. Epub 2023 Jul 7.
6
A MOF/DNA luminescent sensing platform for detection of potential COVID-19 biomarkers and drugs.一种用于检测潜在新冠病毒生物标志物和药物的金属有机框架/DNA发光传感平台。
Chem Sci. 2023 Apr 19;14(20):5386-5395. doi: 10.1039/d3sc00106g. eCollection 2023 May 24.
7
Anti-COVID-19 Potential of Ellagic Acid and Polyphenols of L.鞣花酸和 L. 的多酚的抗 COVID-19 潜力
Molecules. 2023 Apr 27;28(9):3772. doi: 10.3390/molecules28093772.
8
The synergistic effect of Cu-MOF nanoparticles and immunomodulatory agent on SARS-CoV-2 inhibition.铜基金属有机框架纳米颗粒与免疫调节剂对新型冠状病毒抑制的协同作用。
Chem Commun (Camb). 2023 Apr 20;59(33):4907-4910. doi: 10.1039/d3cc00894k.
9
Virus Management Using Metal-Organic Framework-Based Technologies.使用基于金属有机框架的技术进行病毒管理
ACS Appl Mater Interfaces. 2023 Mar 22;15(11):13844-13859. doi: 10.1021/acsami.3c00922. Epub 2023 Mar 9.
10
Surface-Functionalized Metal-Organic Frameworks for Binding Coronavirus Proteins.用于结合冠状病毒蛋白的表面功能化金属有机框架
ACS Appl Mater Interfaces. 2023 Feb 14;15(7):9058-65. doi: 10.1021/acsami.2c21187.